PP01.47: PD-(L)1 Inhibitor Monotherapy Versus Chemo-Immunotherapy for Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and PD-L1 Expression ≥50%: A Systematic Review and Meta-Analysis with Individual Patient Data

作者：Alessandro Di Federico, Samuele Compagno, Francesco Mantuano, Sara Stumpo, Andrea De Giglio, Federica Pecci, J. Alessi, Xinan Wang, Francesca Sperandi, Barbara Melotti, Francesco Gelsomino, Maria A. Pantaleo, Andrea Arfè, Hossein Borghaei, M Garassino, Federico Cappuzzo, Andrea Ardizzoni, Mark M. Awad, Biagio Ricciuti · 发表于：Journal of Thoracic Oncology · 年份：2026 · DOI：10.1016/j.jtho.2026.104045 · 研究领域：Cancer Immunotherapy and Biomarkers、Lung Cancer Treatments and Mutations、Lung Cancer Research Studies